Table 1.
ncRNA | Impact on Osteogenesis | Role in Tumorigenesis | Examined Cell Lines | Targets | References |
---|---|---|---|---|---|
miR-17-5p | downregulation | oncogene | huASCs, MC3T3-E1, MG-63, U-2 OS, Saos-2, 143B | BRCC2, BMP-2, SMAD7, Wnt/β-catenin signaling | 100, 101, 102, 103, 104 |
miR-21 | upregulation downregulation (?) | oncogene | huBMSCs, MC3T3-E1, 4B12, MG-63, U-2 OS, Saos-2, HOS, 143B | SMAD family proteins, RUNX2, OCN, OPN, OCL, COLL-1, MMP-9, OPG, RANKL, RANK, IL-6, IL-8 | 25,27,29,30,105 |
miR-124 | downregulation | suppressor gene | huBMSCs, MG-63 | TGF-β family proteins, DLX family proteins, OSX, CDK2, MPC-1 | 26,41,43, 44, 45 |
miR-149 | downregulation | suppressor gene | raBMSCs, MG-63, U-2 OS, Saos-2, HOS, 143B | ERK/MAPK signaling, SDF-1, PI3K/AKT pathway | 106, 107, 108 |
miR-203 | upregulation downregulation | suppressor gene | huBMSCs, huH226, MG-63, U-2 OS, Saos-2 | RUNX2, DLX5, MMP-1, SMAD3, TGF-β family proteins, IL-6, RAB22A, TBK1 | 47,49,51,54, 55, 56 |
miR-223 | upregulation downregulation | suppressor gene | MC3T3-E1, huBMSCs, 143B, U-2 OS | HDAC2, CSFR1/M-CSFR, CDH6 | 18,58,59,63,109 |
lncDANCR | downregulation | oncogene | huBMSCs, human monocytes, 143B | TNF-α, RANKL, miR-33a-5p, miR-216a-5p/SOX5 | 69,70,110 |
lncTUG1 | upregulation | oncogene | huPDLSCs, huTPSCs, huBMSCs, MG-63, U-2 OS | miR-204, miR-211, miR-132/ SOX4, RUNX2, | 24,74,77 |
lncMALAT1 | upregulation | oncogene | huASCs, huFLSs huFOB1.19, MG-63, U-2 OS, Saos-2 | miR-204, SMAD4, miR-30, miR-124, IL-6, IL-10, TNF-α, CTNNB1 | 4,81,82 |
lncHOTAIR | downregulation | oncogene | huBMSCs, huAVICs, MG-63 | miR-138, miR-204, miR17-5p/SMAD7 axis, Wnt/β-catenin signaling, NF-κB signaling | 4,92,94,111 |
lncH19 | upregulation | oncogene | raBMSCs, raEMSCs, MG-63, U-2 OS, Saos-2, HOB | Wnt/β-catenin signaling, miR-138, miR-149/SDF-1 axis | 107,112, 113, 114, 115 |
ERK, extracellular signal-regulated kinase; MAPK, mitogen-activated protein kinase; AVIC, aortic valve interstitial cell.